Evaluating time to withdrawal of anti-cancer drug indications that received FDA's accelerated approval
(2024) In QJM - Monthly Journal of the Association of Physicians
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/834f54e1-4dba-4cb3-a031-2f6418b8303f
- author
- Hakariya, Hayase ; Ozaki, Akihiko ; Mulinari, Shai LU ; Moriarty, Frank and Tanimoto, Tetsuya
- organization
- publishing date
- 2024-06-12
- type
- Contribution to journal
- publication status
- epub
- subject
- in
- QJM - Monthly Journal of the Association of Physicians
- publisher
- Oxford University Press
- external identifiers
-
- pmid:38867701
- ISSN
- 0033-5622
- DOI
- 10.1093/qjmed/hcae115
- language
- English
- LU publication?
- yes
- id
- 834f54e1-4dba-4cb3-a031-2f6418b8303f
- date added to LUP
- 2024-06-13 16:09:40
- date last changed
- 2024-07-23 15:46:14
@article{834f54e1-4dba-4cb3-a031-2f6418b8303f,
author = {{Hakariya, Hayase and Ozaki, Akihiko and Mulinari, Shai and Moriarty, Frank and Tanimoto, Tetsuya}},
issn = {{0033-5622}},
language = {{eng}},
month = {{06}},
publisher = {{Oxford University Press}},
series = {{QJM - Monthly Journal of the Association of Physicians}},
title = {{Evaluating time to withdrawal of anti-cancer drug indications that received FDA's accelerated approval}},
url = {{http://dx.doi.org/10.1093/qjmed/hcae115}},
doi = {{10.1093/qjmed/hcae115}},
year = {{2024}},
}